Key TakeawaysThe 2024-2025 influenza season was severe, with high illness rates, hospitalizations, and fatalities, emphasizing the need for better vaccines.Moderna’s mRNA-1010 vaccine showed 26.6% overall efficacy and 27.4% efficacy in older adults, with robust strain-specific results.The vaccine demonstrated a favorable safety profile, with mild adverse reactions and no serious vaccine-related events reported.Pharmacists are essential in […]
